Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16619235 | 0.89 | CTSB (0.32) | — | |
| SCHEMBL16618705 | 0.87 | MAPT (0.34) | RAB9AMAPTEGFRERBB2 | |
| SCHEMBL16619327 | 0.78 | PDGFRB (0.41) | MAPTEGFRERBB2 | |
| SCHEMBL16618814 | 0.76 | CTSB (0.33) | RAB9AMAPTEGFRERBB2 | |
| SCHEMBL16618824 | 0.71 | S1PR4 (0.35) | NPC1RECQLRAB9AS1PR4MAPT | |
| SCHEMBL16619181 | 0.71 | S1PR4 (0.40) | NPC1RECQLRAB9AS1PR4EGFR | |
| SCHEMBL16619269 | 0.71 | CYP1A2 (0.42) | NPC1RECQLRAB9AMAPT | |
| SCHEMBL16619494 | 0.70 | MAPT (0.42) | NPC1RAB9AS1PR4MAPT | |
| SCHEMBL16618967 | 0.70 | ENPP1 (0.34) | ENPP1 | |
| SCHEMBL16619572 | 0.69 | EGFR (0.39) | EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015049629-A1 | IMIDAZOQUINOLINE COMPOUNDS AS BROMODOMAIN INHIBITORS | Piramal Enterprises Limited (IN) | 2015-04-09 | — | — | WO | disclosed |